In Raffles Cancer Centre, we actively seek partnerships with research organisations who share our passion in our mission to provide the best cancer care for our patients. Clinical trials constitute an integral component of patient management in Raffles Hospital. Through these trials, our patients have access to novel therapeutic agents, which have yet made available in the market, will give hope even after their conditions have failed to respond to standard lines of treatment.
Our specialists in Raffles Cancer Centre have abundant experience as principal investigators and co-investigators of well over 50 clinical trials in various phases (phase I, II, III), both investigator-initiated and pharmaceutical company-initiated, and as part of larger international multi-centre phase III trials.
Coordinated by the Hospital ‘s Clinical Trial Unit, these trials help expand the treatment options available to patients.
All clinical trials involving humans are subjected to approval by the Hospital’s Institutional Review Board (IRB) which ensures all clinical trials are ethically acceptable and that the rights, safety and well –being of the patients are safeguarded at all times. The IRB also monitors the conduct of the clinical trials and ensures that they are in compliance with Good Clinical Practice on an ongoing basis.